Fiduccia, I., Vitale, E., Varrica, R., Ricci, D., Marino, S., Zito, A., Pace, A., Colige, A., Moutschen, M., Borutzki, Y., Bileck, A., Meier-Menches, S. M., Lentini, L., & Pibiri, I. (2026). Beyond the stop: Oxadiazole TRIDs restore LRBA protein expression in nonsense-driven primary immunodeficiency. Molecular Therapy Nucleic Acids, 37(1), Artikel 102808. https://doi.org/10.1016/j.omtn.2025.102808

Bormio Nunes, J. H., Hacker, C., Caban, M., Valcanover, D., Yassemipour, P. A., Türck, S., Ott, I., Skos, L., Bileck, A., Gerner, C., Meier-Menches, S. M., Mohr, T., Berger, W., Kowol, C. R., & Heffeter, P. (2026). Structure-Activity Relationships of Silver(I)- and Gold(I)-NHC Complexes Reveal Distinctly Different Responses of Cisplatin-Resistant Ovarian Cancer to Bis-NHC-Gold(I) Derivatives. Journal of Medicinal Chemistry, Artikel PMID 9716531. Vorzeitige Online-Publikation. https://doi.org/10.1021/acs.jmedchem.5c02355

Thomas, S. R., Iellici, T., Park, M., Klaus, E., Bileck, A., Gerner, C., Meier-Menches, S. M., & Casini, A. (2026). A Gold-PROTAC Degrades the Oncogenic Tyrosine Kinase MERTK: Insights into the Degradome from a Steady-State System. ACS Chemical Biology, 21(1), 170-186. https://doi.org/10.1021/acschembio.5c00860

Elkhamary, A., Gerner, C., Bileck, A., Gerner, I., & Jenner, F. (2025). Proteomic and morphologic characterization of ovine macrophage differentiation and polarization. Scientific Reports, 16(1), 693. https://doi.org/10.1038/s41598-025-30269-x

Hagn, G., Cho, A., Zila, N., Sterniczky, B., Jantschitsch, C., Dong, D., Bileck, A., Koren, M., Paulitschke, P., Mohr, T., Knobler, R., Weninger, W. P., Gerner, C., & Paulitschke, V. (2025). Extracorporeal photopheresis induces the release of anti-inflammatory fatty acids and oxylipins and suppresses pro-inflammatory sphingosine-1-phosphate. Inflammation Research, 74(1), Artikel 40. https://doi.org/10.1007/s00011-025-02007-6

Tarasova, K., Arteaga, M. B., Kidtiwong, A., Nivarthi, H., Gamauf, J., Corso, G., Gültekin, S., Bileck, A., Rothbauer, M., Toegel, S., Hackl, M., Kau-Strebinger, S., Gerner, C., Grillari, R., Gerner, I., & Jenner, F. (2025). Ontogenetic stage and type of donor cells shape extracellular vesicles’ therapeutic potential for osteoarthritis. Stem Cell Research and Therapy, 16(1), Artikel 478. https://doi.org/10.1186/s13287-025-04585-y

Outla, Z., Kosla, J., Prechova, M., Frick, L., Janker-Bortel, P., Borutzki, Y., Bileck, A., Gerner, C., Meier-Menches, S. M., Osmanagic-Myers, S., & Gregor, M. (2025). Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin. Molecular Oncology. Vorzeitige Online-Publikation. https://doi.org/10.1002/1878-0261.70186

Paulitschke, V., Wolf, M., Wasinger, D., Zila, N., Bileck, A., Stary, G., Borik-Heil, L., Dadak, L., Aguilar-Gonzales, A., Harikumar, N., Tuchmann, F., Fischer, A., Stando, S., Kunstfeld, R., Weninger, W. P., Höller, C., & Gerner, C. (2025). In silico Identification of Metastasis-Associated Gene Signatures in Cutaneous Melanoma using Bulk RNA-Sequencing-based Pathway Enrichment and Machine Learning. Journal der Deutschen Dermatologischen Gesellschaft, 23(S6), 100-101. Artikel Meeting Abstract: eP115.

Jobst, M., Crudo, F., Marko, D., Bileck, A., Meier-Menches, S. M., Gerner, C., & Del Favero, G. (2025). Retrograde rearrangement of mitochondria correlates with nuclear deformation and genotoxic damage. Iscience, 28(8), Artikel 112955. https://doi.org/10.1016/j.isci.2025.112955

Rosner, A., Skos, L., Mendrina, T., Baier-Romfeld, D., Hejl, M., Borutzki, Y., Gradl, M., Geisler, H., Mohr, T., Legin, A., Jakupec, M. A., Bileck, A., Gerner, C., Koellensperger, G., Heffeter, P., Berger, W., Keppler, B. K., Kandioller, W., & Meier-Menches, S. M. (2025). Selectivity for TP53 signalling drives the mode of action of a highly potent N,O,O-tridentate naphthoquinone-based organo-ruthenium anticancer drug candidate. Chemical Science. Vorzeitige Online-Publikation. https://doi.org/10.1039/d5sc00735f

Schmidl, D., Pai, V., Bileck, A., Hommer, N., Janku, P., Lindner, T., Kauer, V., Rumpf, B., Haslacher, H., Hagn, G., Meier-Menches, S. M., Schmetterer, L., Gerner, C., & Garhöfer, G. (2025). Retinal microcirculation in patients that have recovered from acute COVID-19 infection. Journal of Vascular Research, 62(SUPPL 1), Artikel Meeting Abstract 90.

Hagn, G., Bileck, A., Mohr, T., Schmidl, D., Baron, D. M., Jilma, B., Schmetterer, L., Garhöfer, G., & Gerner, C. (2025). Time Course of Plasma Proteomic and Oxylipin Changes Induced by LPS Challenge and Modulated by Antioxidant Supplementation in a Randomized Controlled Trial. Antioxidants, 14(5), Artikel 536. https://doi.org/10.3390/antiox14050536

Outla, Z., Oyman-Eyrilmez, G., Korelova, K., Prechova, M., Frick, L., Sarnova, L., Bisht, P., Novotna, P., Kosla, J., Janker-Bortel, P., Borutzki, Y., Bileck, A., Gerner, C., Rahbari, M., Rahbari, N., Birgin, E., Kvasnicova, B., Galisova, A., Sulkova, K., ... Gregor, M. (2025). Plectin-mediated cytoskeletal crosstalk as a target for inhibition of hepatocellular carcinoma growth and metastasis. eLife, 13. https://doi.org/10.7554/eLife.102205

Bolliger, M., Wasinger, D., Brunmair, J., Hagn, G., Wolf, M., Preindl, K., Reiter, B., Bileck, A., Gerner, C., Fitzal, F., & Meier-Menches, S. M. (2025). Mass spectrometry-based analysis of eccrine sweat supports predictive, preventive and personalised medicine in a cohort of breast cancer patients in Austria. The EPMA journal, 16(1), 165-182. https://doi.org/10.1007/s13167-025-00396-6

Zott, T., Wolf, M., Plessl-Walder, G., Regele, H., Bergmann, M., Meier-Menches, S. M., Gerner, C., Silberhumer, G. R., & Bileck, A. (2025). Proteomic Analysis of FFPE Tissue Samples Identifies Potential Molecular Mechanisms Mediating Resistance to Radiotherapy in Rectal Cancer. Journal of Proteome Research. Vorzeitige Online-Publikation. https://doi.org/10.1021/acs.jproteome.5c00114

Elkhamary, A., Gerner, I., Bileck, A., Oreff, G. L., Gerner, C., & Jenner, F. (2024). Comparative proteomic profiling of the ovine and human PBMC inflammatory response. Scientific Reports, 14(1), Artikel 14939. https://doi.org/10.1038/s41598-024-66059-0

Paulitschke, V., Zila, N., Bileck, A., Stary, G., Borik-Heil, L., Dadak, L., Wolf, M., Wasinger, D., Aguilar-Gonzales, A., Harikumar, N., Kunstfeld, R., Weninger, W., Hoeller, C., & Gerner, C. (2024). Proteomic and Metabolomic Profiling of Female Patients with advanced Melanoma to Predict and Monitor Response to anti-PD1 Immunotherapy. Journal der Deutschen Dermatologischen Gesellschaft, 22(Suppl. 4), 33-34. Artikel Meeting Abstract FV46.

Hagn, G., Meier-Menches, S. M., Plessl-Walder, G., Mitra, G., Mohr, T., Preindl, K., Schlatter, A., Schmidl, D., Gerner, C., Garhöfer, G., & Bileck, A. (2024). Plasma Instead of Serum Avoids Critical Confounding of Clinical Metabolomics Studies by Platelets. Journal of Proteome Research, 23(8), 3064-3075. https://doi.org/10.1021/acs.jproteome.3c00761

Gerner, I., Meier-Menches, S. M., Bileck, A., Gueltekin, S., Gerner, C., & Jenner, F. (2024). Metabolic Profiling Of Tendon And Cartilage Healing. Tissue engineering. Part A, 30(15-16), S6-S7.

Skos, L., Schmidt, C., Thomas, S. R., Park, M., Geiger, V., Wenisch, D., Bonsignore, R., Del Favero, G., Mohr, T., Bileck, A., Gerner, C., Casini, A., & Meier-Menches, S. M. (2024). Gold-templated covalent targeting of the CysSec-dyad of thioredoxin reductase 1 in cancer cells. Cell Reports Physical Science, 5(7), Artikel 102072. https://doi.org/10.1016/j.xcrp.2024.102072